InMed Pharmaceuticals Soars on Alzheimer’s Breakthrough: What’s Driving the Surge?
Buckle up, traders! As of this writing, InMed Pharmaceuticals Inc. (NASDAQ: INM) is lighting up the market with a jaw-dropping gain of over 100%, trading at $4.91 per share. This tiny biotech, headquartered in Vancouver, Canada, is making waves with a game-changing...